Filing Flows › iBio (IBIO) › R&D spending
iBio (IBIO) R&D spending by quarter
iBio's R&D spending was $3.5M in Q1 FY26 (first quarter fiscal 2026), +10% from Q4 FY25. Over the last 3 quarters it ranged from $1.9M (Q2 FY25) to $3.5M (Q1 FY26).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY26 | $3.5M | +10% | — |
| Q4 FY25 | $3.2M | +72% | — |
| Q2 FY25 | $1.9M | — | — |
Q1 FY26 at a glance
iBio, Q1 FY26: revenue $100K, net loss $5.7M, operating cash flow −$5.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is iBio's R&D spending?
iBio's R&D spending was $3.5M in Q1 FY26 (first quarter fiscal 2026), +10% from Q4 FY25.
How has iBio's R&D spending changed?
Over the last 3 quarters it ranged from $1.9M (Q2 FY25) to $3.5M (Q1 FY26).